CSTF2T expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 2.204000E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
3.262800E-01
Normal-vs-Stage2
2.265900E-02
Normal-vs-Stage3
8.894300E-02
Normal-vs-Stage4
4.061000E-01
Stage1-vs-Stage2
2.498600E-01
Stage1-vs-Stage3
3.083600E-02
Stage1-vs-Stage4
7.128400E-01
Stage2-vs-Stage3
1.767830E-01
Stage2-vs-Stage4
6.880000E-01
Stage3-vs-Stage4
3.142000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
2.304200E-02
Normal-vs-AfricanAmerican
3.299600E-01
Normal-vs-Asian
4.186400E-02
Caucasian-vs-AfricanAmerican
2.452800E-01
Caucasian-vs-Asian
3.050600E-01
AfricanAmerican-vs-Asian
8.860400E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
2.112000E-02
Normal-vs-Female
3.573600E-02
Male-vs-Female
4.816600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
2.764000E-01
Normal-vs-Age(41-60Yrs)
4.153200E-01
Normal-vs-Age(61-80Yrs)
2.630500E-02
Normal-vs-Age(81-100Yrs)
3.156400E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
5.214000E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
9.444800E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
9.407800E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
2.053800E-02
Age(41-60Yrs)-vs-Age(81-100Yrs)
1.802840E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
9.670200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
1.900040E-02
Normal-vs-Daily Drinker
2.497800E-01
Normal-vs-Weekly Drinker
8.370500E-02
Normal-vs-Occasional Drinker
3.102200E-01
Normal-vs-Social Drinker
1.174840E-01
Non Drinker-vs-Daily Drinker
5.089600E-01
Non Drinker-vs-Weekly Drinker
4.090200E-01
Non Drinker-vs-Occasional Drinker
6.838600E-01
Non Drinker-vs-Social Drinker
1.668240E-01
Daily Drinker-vs-Weekly Drinker
1.696640E-01
Daily Drinker-vs-Occasional Drinker
2.832200E-01
Daily Drinker-vs-Social Drinker
5.439800E-02
Weekly Drinker-vs-Occasional Drinker
6.152400E-01
Weekly Drinker-vs-Social Drinker
6.380000E-01
Occasional Drinker-vs-Social Drinker
2.837000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
1.749010E-01
Normal-vs-Grade 2
4.322200E-02
Normal-vs-Grade 3
5.650200E-02
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
9.950200E-01
Grade 1-vs-Grade 3
6.863600E-01
Grade 1-vs-Grade 4
1.749010E-01
Grade 2-vs-Grade 3
4.994000E-01
Grade 2-vs-Grade 4
4.322200E-02
Grade 3-vs-Grade 4
5.650200E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
3.858400E-02
Normal-vs-NonDiabetic
3.029000E-01
Diabetic-vs-NonDiabetic
8.993800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
2.955000E-01
Normal-vs-NoPancreatitis
3.102800E-01
Pancreatitis-vs-NoPancreatitis
7.671800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
6.768500E-02
Normal-vs-N1
3.299200E-01
N0-vs-N1
5.236800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
3.134000E-01
Normal-vs-TP53-NonMutant
2.147200E-01
TP53-Mutant-vs-TP53-NonMutant
2.229900E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
